Pharmaceutical News

RSS

Preoperative statin therapy improves results for isolated CABG and AVR operations

Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate), according to an article in the October 2013 issue of The Annals of Thoracic Surgery.

1 Oct 2013

ABAM Foundation receives $2M grant to establish Center for Physician Training in Addiction Medicine

The Conrad N. Hilton Foundation has awarded the American Board of Addiction Medicine (ABAM) Foundation a three-year, $2 million grant to establish The National Center for Physician Training in Addiction Medicine.

1 Oct 2013

Mayo Clinic researchers to develop innovative medical treatments for wounded veterans

Mayo Clinic researchers are part of the second phase of a national consortium that focuses on developing innovative medical treatments for wounded veterans. Mayo's role will emphasize peripheral nerve regeneration.

1 Oct 2013

Use of cocaine may increase one's vulnerability to HIV infection

Cocaine use may increase one's vulnerability to HIV infection, according to a new research report published in the Journal of Leukocyte Biology. In the report, scientists show that cocaine alters immune cells, called "quiescent CD4 T cells," to render them more susceptible to the virus, and at the same time, to allow for increased proliferation of the virus.

1 Oct 2013

FDA approves Brintellix drug to treat depressive disorder in adults

The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.

1 Oct 2013

U.K. Gov’T Awards AMRI A Development And Manufacture Contract

Albany Molecular Research (AMRI) reported that its Holywell, Wales-based wholly owned subsidiary AMRI U.K., has been awarded a seven-year contract for the development and manufacture of an undisclosed active ingredient under clinical evaluation.

30 Sep 2013

Researchers discover how aspirin improves survival in patients with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress heard today (Monday).

30 Sep 2013

Use of psychotropic prescription medications in very young children stabilizing

The use of psychotropic prescription medications to treat ADHD, mood disorders, anxiety and other mental health disorders in very young children appears to have leveled off.

30 Sep 2013

Mylan Pharmaceuticals launches Voriconazole for Oral Suspension

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Voriconazole for Oral Suspension, 40 mg/mL, which is the first generic version of Pfizer's VFEND for Oral Suspension.

30 Sep 2013

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European Cancer Congress.

30 Sep 2013

Omeros' OMS824 gets FDA orphan drug designation for treatment of Huntington's disease

Omeros Corporation announced that OMS824, its phosphodiesterase 10 inhibitor, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Huntington's disease.

30 Sep 2013

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.

30 Sep 2013

Study reveals new findings on role of psychotherapy in regulating serotonin receptors

A paper published in the current issue of Psychotherapy and Psychosomatics provides new findings on the role of psychotherapy in regulating serotonin receptors.

30 Sep 2013

Innovative packaging design aids convergence in the pharmaceutical industry

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing how it’s innovative packaging design aids convergence in the pharmaceutical industry.

30 Sep 2013

Chinese and Western medicine combination could offer new hope for cancer treatments, therapies

Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones.

30 Sep 2013

Biochemists discover promising vitamin D-based treatment that can halt MS

A diagnosis of multiple sclerosis is a hard lot. Patients typically get the diagnosis around age 30 after experiencing a series of neurological problems such as blurry vision, wobbly gait or a numb foot. From there, this neurodegenerative disease follows an unforgiving course.

29 Sep 2013

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013

Ablynx Nets Another $33.7M From Merck Serono As Partnership Expands

...

27 Sep 2013

Dextrose gel could treat neonatal hypoglycemia

A cheap and easy-to-administer dextrose gel should be used to treat low blood sugars in newborns (neonatal hypoglycaemia), a common problem that affects up to 15% of otherwise healthy babies, and a preventable cause of brain damage, according to new research published in The Lancet.

27 Sep 2013

Four Geisinger Health System researchers receive $25M grant to initiate ClinGen Project

Four Geisinger Health System researchers have taken center stage in the national arena of genomics thanks to new funding from the National Human Genome Research Institute (NHGRI), an arm of the U.S. National Institutes of Health (NIH).

27 Sep 2013

Pharmaceutical News

Preoperative statin therapy improves results for isolated CABG and AVR operations

ABAM Foundation receives $2M grant to establish Center for Physician Training in Addiction Medicine

Mayo Clinic researchers to develop innovative medical treatments for wounded veterans

Use of cocaine may increase one's vulnerability to HIV infection

FDA approves Brintellix drug to treat depressive disorder in adults

U.K. Gov’T Awards AMRI A Development And Manufacture Contract

Researchers discover how aspirin improves survival in patients with colon cancer

Use of psychotropic prescription medications in very young children stabilizing

Mylan Pharmaceuticals launches Voriconazole for Oral Suspension

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Omeros' OMS824 gets FDA orphan drug designation for treatment of Huntington's disease

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Study reveals new findings on role of psychotherapy in regulating serotonin receptors

Innovative packaging design aids convergence in the pharmaceutical industry

Chinese and Western medicine combination could offer new hope for cancer treatments, therapies

Biochemists discover promising vitamin D-based treatment that can halt MS

FDA expands Hizentra administration options for people with primary immunodeficiency

Ablynx Nets Another $33.7M From Merck Serono As Partnership Expands

Dextrose gel could treat neonatal hypoglycemia

Four Geisinger Health System researchers receive $25M grant to initiate ClinGen Project

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News